Alerting the Body to Tissue Injury: The Role of Alarmins and DAMPs in Cutaneous Wound Healing
- 92 Downloads
Purpose of Review
Tissue injury stimulates an inflammatory response that is mediated in part by alarmins. Alarmins are a group of endogenous molecules that trigger inflammation in response to damage. This class of molecules is becoming increasingly recognized for its ability to influence wound healing. This article will provide an overview of alarmins and outline the latest findings on these mediators in cutaneous wound healing.
In addition to stimulating inflammatory cells, recent evidence suggests that alarmins can act on other cells in the skin to affect wound closure and the extent of scar tissue production. This review will focus on high-mobility group box-1 and IL-33, two alarmins that have received recent attention in the wound healing field.
Because a properly regulated inflammatory response is critical for optimal healing, further research must be done to fully understand the role of alarmins in the wound repair process.
KeywordsHMGB-1 Inflammation IL-33 Repair Skin Wound
NIH funding (R21 ES022749 to TAW) is acknowledged.
Compliance with Ethical Standards
Conflict of Interest
Dr. Wilgus has nothing to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 4.• Millar NL, O'Donnell C, McInnes IB, Brint E. Wounds that heal and wounds that don’t—the role of the IL-33/ST2 pathway in tissue repair and tumorigenesis. Semin Cell Dev Biol. 2017;61:41–50. This is an informative review article on IL-33 signaling and the role of this pathway in the repair of multiple tissue types. https://doi.org/10.1016/j.semcdb.2016.08.007.CrossRefPubMedGoogle Scholar
- 8.Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155(4):1137–46. https://doi.org/10.1016/S0002-9440(10)65217-0.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Hirth DA, Singer AJ, Clark RA, McClain SA. Histopathologic staining of low temperature cutaneous burns: comparing biomarkers of epithelial and vascular injury reveals utility of HMGB1 and hematoxylin phloxine saffron. Wound Repair Regen. 2012;20(6):918–27. https://doi.org/10.1111/j.1524-475X.2012.00847.x.CrossRefPubMedGoogle Scholar
- 19.Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781–6. https://doi.org/10.1161/01.CIR.0000039526.42991.93.CrossRefPubMedGoogle Scholar
- 22.Schurmann C, Linke A, Engelmann-Pilger K, Steinmetz C, Mark M, Pfeilschifter J, et al. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice. J Pharmacol Exp Ther. 2012;342(1):71–80. https://doi.org/10.1124/jpet.111.191098.CrossRefPubMedGoogle Scholar
- 26.Zhang Q, O'Hearn S, Kavalukas SL, Barbul A. Role of high mobility group box 1 (HMGB1) in wound healing. J Surg Res. 2011.Google Scholar
- 30.Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D, et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine. 2008;42(3):358–64. https://doi.org/10.1016/j.cyto.2008.03.008.CrossRefPubMedGoogle Scholar
- 33.Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 2012;188(7):3488–95. https://doi.org/10.4049/jimmunol.1101977.CrossRefPubMedGoogle Scholar
- 34.Kuchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol. 2008;173(4):1229–42. https://doi.org/10.2353/ajpath.2008.080014.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.• Rak GD, Osborne LC, Siracusa MC, Kim BS, Wang K, Bayat A, et al. IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J Invest Dermatol. 2016;136(2):487–496. This paper demonstrates an important role for IL-33 in the recruitment of ILC2 cells during skin repair. https://doi.org/10.1038/JID.2015.406.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.• Oshio T, Komine M, Tsuda H, Tominaga SI, Saito H, Nakae S, et al. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice. J Dermatol Sci. 2017;85(2):106–114. This study suggests opposing nuclear and extracellular activities of IL-33 in wound healing. https://doi.org/10.1016/j.jdermsci.2016.10.008.CrossRefPubMedGoogle Scholar